Creating partnerships to advance new drug discovery that will provide better treatment options for cancer patients

Despite the progress made in in the last decades in cancer research, in many occasions the clinical adoption of these advances takes years. A number of reasons contribute to this, and adds the need to demonstrate the safety, efficacy and dosage of a novel compound before being approved by healthcare authorities. This process makes it slower for patients to have access to much needed new treatment alternatives.

PH Research partners with biotech companies in the development of new cancer drugs to reduce the time gap from when research of a molecule begins and when it is available to patients.